About
iota Biosciences, Inc., a subsidiary of Astellas, is a medical device company that develops advanced bioelectronic diagnostic and therapeutic devices. Founded in 2017, the company utilizes award-winning ultrasound technology from the University of California, Berkeley, to create innovative bioelectronic implants. These devices aim to enhance disease management and treatment options beyond traditional pharmaceuticals. The core technology at iota leverages ultrasonic energy to wirelessly power and communicate with small implantable medical devices. This approach enables the development of non-pharmaceutical solutions for chronic diseases, including a device for underactive bladder that is currently in early feasibility clinical trials. iota collaborates with Astellas to advance multiple bioelectronic projects, focusing on bringing these therapies to clinical testing and patient use. iota Biosciences serves healthcare providers and patients seeking new treatment options for chronic conditions. The company combines the agility of a biotech startup with the resources of a global pharmaceutical leader, fostering a culture of innovation and quality in bioelectronic medicine.
Technologies
Keywords
Company Information
-
Employees 96
-
Founded 2017
-
Annual Revenue $12830000000
-
Total Funding $30000002
Location
400 Wind River Way, Alameda, California, United States, 94501-1193
